WeRide, Renault Bring Autonomous Shuttles Back To Roland-Garros In Paris

WeRide WRD, a leading global developer of autonomous driving technology, announced on Tuesday it will once again partner with Renault Group, a key Roland-Garros sponsor, to provide a Level-4 self-driving minibus shuttle during the 2025 Grand Slam tennis tournament in Paris.

The return of the Robobus service highlights the successful partnership between the two companies. After a dependable debut last year, the shuttle will run a 2.8-kilometer loop connecting key venues around Roland-Garros daily from May 25 to June 8.

A new addition for this year is a night schedule, operational from 10 p.m. to midnight, thereby enhancing access during periods of low light.

Also Read: Toyota Restructures Complex Shareholding Pattern In Mobility Push

Tony Han, WeRide’s founder and CEO, emphasized the importance of their continued presence at Roland-Garros and their focus on expanding in Europe.

Patrick Vergelas, Autonomous Mobility Project Manager at Renault Group, highlighted the growing societal acceptance of autonomous transit. “From Roland-Garros to Barcelona, via Valence, Renault and WeRide demonstrate that autonomous mobility is no longer a promise, but a reality,” he stated.

This initiative follows WeRide and Renault’s launch in March 2025 of Europe’s first fully driverless commercial Robobus in France’s Drôme region and a Level-4 autonomous shuttle trial in Barcelona. Powered by WeRide’s proprietary system, the Robobus operates in nearly 30 cities worldwide, including Singapore, Switzerland, France, and China.

WeRide reported $10 million in revenue for the first quarter of 2025, a 1.8% increase year-over-year. Product sales, including robotaxis and robosweepers, rose to $1.3 million. The robotaxi segment grew to 22.3% of total revenue. Gross margin remained steady at 35%.

ETFs such as the Global X Autonomous & Electric Vehicles ETF DRIV and the iShares Self-Driving EV and Tech ETF IDRV also provide exposure to this emerging market.

Price Action: WRD shares are trading lower by 2.55% to $9.55 at last check Tuesday.

Read Next:

• Merck’s Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report

Photo by Tada Images via Shutterstock